Kaleido Biosciences, Inc. (KLDO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 29, 2026
Kaleido Biosciences Market Cap
Kaleido Biosciences has a market cap or net worth of $4.26 thousand as of October 30, 2026. It is the 52,100th most valuable company in the world and the 8,080th biggest in the United States.
Market Cap
4.26K
Enterprise Value
n/a
Revenue
1.10M
Global Rank
Country Rank
#8,080 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since February 28, 2019, Kaleido Biosciences's market cap has decreased from 413.61M to 4.26K, a decrease of -100.00%. That is a compound annual growth rate of -77.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 4.26K | - |
| Dec 30, 2025 | 4.26K | 9,811.63% |
| Dec 31, 2024 | 43.00 | - |
| Dec 29, 2023 | 43.00 | -99.80% |
| Dec 30, 2022 | 21.31K | -99.98% |
| Dec 31, 2021 | 101.80M | -68.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| FluoroPharma Medical | 5.52K |
| Better Therapeutics | 5.45K |
| LadRx | 5.45K |
| MultiCell Technologies | 5.00K |
| Arno Therapeutics | 4.98K |
| ONE Bio | 4.19K |
| MetaStat | 4.11K |
| Baseline Productions | 4.11K |